Literature DB >> 25569376

Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional.

Wenji Sun1, Yi Wang2, James E East1, Amy S Kimball3, Katherine Tkaczuk3, Susan Kesmodel4, Scott E Strome5, Tonya J Webb6.   

Abstract

Invariant natural killer T (iNKT) cells constitute an important subset of T cells that can both directly and indirectly mediate anti-tumor immunity. However, cancer patients have a reduction in both iNKT cell number and function, and these deficits limit the potential clinical application of iNKT cells for cancer therapy. To overcome the problem of limited iNKT cell numbers, we investigated whether iNKT cells can be generated in vitro from bone marrow-derived adult hematopoietic stem-progenitor cells (HSPC). Our data demonstrate that co-culture of HSPC with OP9-DL1 stromal cells, results in a functional CD3(+) T cell population. These T cells can be further differentiated into iNKT cells by secondary culture with CD1d-Ig-based artificial antigen-presenting cells (aAPC). Importantly, these in vitro-generated iNKT cells are functional, as demonstrated by their ability to proliferate and secrete IFN-γ and GM-CSF following stimulation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adoptive immunotherapy; CD1d; NKT cells; Stem cells

Mesh:

Substances:

Year:  2015        PMID: 25569376      PMCID: PMC4329102          DOI: 10.1016/j.cyto.2014.12.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  48 in total

1.  Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro.

Authors:  Thomas M Schmitt; Renée F de Pooter; Matthew A Gronski; Sarah K Cho; Pamela S Ohashi; Juan Carlos Zúñiga-Pflücker
Journal:  Nat Immunol       Date:  2004-03-21       Impact factor: 25.606

Review 2.  T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!

Authors:  D L Porter; C H June
Journal:  Bone Marrow Transplant       Date:  2005-05       Impact factor: 5.483

3.  Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients.

Authors:  S Maury; J Y Mary; C Rabian; M Schwarzinger; A Toubert; C Scieux; M Carmagnat; H Esperou; P Ribaud; A Devergie; P Guardiola; P Vexiau; D Charron; E Gluckman; G Socié
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

Review 4.  Cancer immunotherapy comes of age.

Authors:  Suzanne L Topalian; George J Weiner; Drew M Pardoll
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

5.  Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.

Authors:  Tonya J Webb; Joan G Bieler; Jonathan P Schneck; Mathias Oelke
Journal:  J Immunol Methods       Date:  2009-05-14       Impact factor: 2.303

6.  Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cells.

Authors:  Takayuki Shiratsuchi; Jonathan Schneck; Akira Kawamura; Moriya Tsuji
Journal:  J Immunol Methods       Date:  2009-04-15       Impact factor: 2.303

7.  Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation.

Authors:  Ginna G Laport; Bruce L Levine; Edward A Stadtmauer; Stephen J Schuster; Selina M Luger; Stephan Grupp; Nancy Bunin; Frank J Strobl; Julio Cotte; Zhaohui Zheng; Brian Gregson; Patricia Rivers; Robert H Vonderheide; David N Liebowitz; David L Porter; Carl H June
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

8.  Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.

Authors:  James E East; Wenji Sun; Tonya J Webb
Journal:  J Vis Exp       Date:  2012-12-29       Impact factor: 1.355

9.  Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.

Authors:  Shin-Ichiro Fujii; Kanako Shimizu; Caroline Smith; Laura Bonifaz; Ralph M Steinman
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

Review 10.  NKT cells as an ideal anti-tumor immunotherapeutic.

Authors:  Shin-Ichiro Fujii; Kanako Shimizu; Yoshitaka Okamoto; Naoki Kunii; Toshinori Nakayama; Shinichiro Motohashi; Masaru Taniguchi
Journal:  Front Immunol       Date:  2013-12-02       Impact factor: 7.561

View more
  7 in total

Review 1.  Immunotherapeutic strategies targeting natural killer T cell responses in cancer.

Authors:  Susannah C Shissler; Dominique R Bollino; Irina V Tiper; Joshua P Bates; Roshanak Derakhshandeh; Tonya J Webb
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

Review 2.  Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy.

Authors:  Huang Zhu; Yi-Shin Lai; Ye Li; Robert H Blum; Dan S Kaufman
Journal:  Stem Cells       Date:  2018-01-03       Impact factor: 6.277

Review 3.  Natural Killer T Cells in Cancer Immunotherapy.

Authors:  Shiny Nair; Madhav V Dhodapkar
Journal:  Front Immunol       Date:  2017-09-22       Impact factor: 7.561

Review 4.  Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy.

Authors:  Cai Zhang; Yuan Hu; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2021-07-15       Impact factor: 22.096

Review 5.  Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy.

Authors:  Susannah C Shissler; Michael S Lee; Tonya J Webb
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

Review 6.  Dengue-associated hemophagocytic lymphohistiocytosis in an adult: A case report and literature review.

Authors:  Sang Mi Chung; Joon Young Song; Wonshik Kim; Min Joo Choi; Ji Ho Jeon; Seonghui Kang; Eunju Jung; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

Review 7.  Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.

Authors:  Pui Yeng Lam; Michael D Nissen; Stephen R Mattarollo
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.